Citation Impact
Citing Papers
Phenotypic and functional features of human Th17 cells
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
2006
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Effects of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells on T and B Lymphocytes from BXSB Mice
2005
Immunogenicity of Adult Mesenchymal Stem Cells: Lessons from the Fetal Allograft
2005
The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells
2007
Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands
2007
Mesenchymal stem cells avoid allogeneic rejection
2005
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells
2003
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
2008
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Immunologic properties of human fetal mesenchymal stem cells
2004
Mesenchymal Stem Cells Inhibit Dendritic Cell Differentiation and Function by Preventing Entry Into the Cell Cycle
2007
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium
2004
Acute Antibody-mediated Rejection of Cardiac Transplants
2006
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Mesenchymal stem cells in health and disease
2008 Standout
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
2006
Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen‐induced arthritis
2007
Immunoregulatory function of mesenchymal stem cells
2006
Murine marrow‐derived mesenchymal stem cell: isolation, in vitro expansion, and characterization
2003
Crohn's disease
2012 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Mesenchymal stem cells: the fibroblasts' new clothes?
2008
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury
2012 Standout
Mesenchymal stem cells in tumor development
2012
The bone marrow niche for haematopoietic stem cells
2014 StandoutNature
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Functions of natural killer cells
2008 Standout
Classification and biology of tumour associated stromal cells
2015
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
2010
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
2003
Adult stem cells in the treatment of autoimmune diseases
2006
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Sepsis and septic shock
2018 Standout
3D bioprinting of tissues and organs
2014 Standout
Surgical options in young adults with aortic valve disease
2003
The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo
2003
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
2010 StandoutNature
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
2013 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A
2011 StandoutNobel
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse
2007
Mesenchymal stem cells: a new strategy for immunosuppression?
2007
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
2006 Nature
Microenvironmental regulation of metastasis
2008 Standout
Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice
2005
Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair
2006
Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes
2004
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Emerging drugs for the treatment of sepsis
2016
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
2011
Immunomodulatory effects of fetal and adult mesenchymal stem cells
2003
HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells
2003 Standout
Immune modulation by mesenchymal stem cells
2006
Idiopathic pulmonary fibrosis
2011 Standout
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
2004
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway
2005
IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells
2007
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
2005
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms
2005
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
2008
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients
2005
Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice
2006
Mesenchymal stem cells induce apoptosis of activated T cells
2005
Strontium can increase some osteoblasts without increasing hematopoietic stem cells
2007
Adipose Tissue‐Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft‐Versus‐Host Disease
2006
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
2005
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
2004 Standout
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation
2007
Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells
2005
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells
2007
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Toll-Like Receptor-3-Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils
2011
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
2005
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice
2005
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
2003
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Mesenchymal stem cells inhibit natural killer–cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
2007
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
2005
The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic
2004
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
2007
Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics
2004
Graft-versus-leukemia effects of transplantation and donor lymphocytes
2008
In Search of the In Vivo Identity of Mesenchymal Stem Cells
2008
Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells through Activation of the Notch Pathway
2008
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
2007 Standout
The Potential of Mesenchymal Stromal Cells as a Novel Cellular Therapy for Multiple Sclerosis
2012
Multipotent mesenchymal stromal cells and immune tolerance
2007
Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
2005
Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells
2007
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Human Adipose Tissue Is a Source of Multipotent Stem Cells
2002 Standout
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
2006
Human mesenchymal stem cells modulate B-cell functions
2005
Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells
2005
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
2007
Stem Cells as a Source of Regenerative Cardiomyocytes
2006
Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice
2006
Local Irradiation Not Only Induces Homing of Human Mesenchymal Stem Cells at Exposed Sites but Promotes Their Widespread Engraftment to Multiple Organs: A Study of Their Quantitative Distribution After Irradiation Damage
2005
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
2005
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness
2004
Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells
2004 Standout
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens
2008
Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells
2009
Mesenchymal Stem Cells: Mechanisms of Inflammation
2011
Contribution of bone marrow-derived fibrocytes to liver fibrosis.
2015
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells
2010 StandoutNobel
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells
2006
Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells
2007
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
2005
Works of R. Laylor being referenced
Engraftment of Allogeneic Hematopoietic Stem Cells Requires Both Inhibition of Host-Versus-Graft Responses and ‘Space' for Homeostatic Expansion
2005
Humoral immune response to human aortic valve homografts
1995
The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation
1993
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide
2001
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide
2003
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro
2004